The Food and Drug Administration is tentatively planning an advisory panel to meet Oct. 22 to discuss a Covid-19 vaccine, the agency’s deputy commissioner for medical and scientific affairs Anand Shah said. Shah did not specify which vaccines, or how many, may be scrutinized at the meeting.
- The committee may also be bolstered by scientific experts on the novel coronavirus, Shah said on a call with reporters
- Investors have been trying to handicap when a vaccine may receive a regulatory nod, with some arguing that an authorization could come
prior to the Nov. 4 U.S. general election - Companies
leading the...
- Investors have been trying to handicap when a vaccine may receive a regulatory nod, with some arguing that an authorization could come